Trial Profile
Postmarketing study investigating the safety and efficacy of recombinant human thrombomodulin treatment of disseminated intravascular coagulation (DIC) in neonatal patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2016
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation
- Focus Adverse reactions; Therapeutic Use
- 02 Jan 2016 New trial record